维生素D3、欧米伽-3脂肪酸和运动对血清硬化蛋白水平及骨转换标志物的影响
DO-HEALTH试验的预设二次分析纳入1848名健康活跃老年人,评估2000 IU/天维生素D3、1 g/天欧米伽-3脂肪酸及简易家庭力量锻炼项目(SHEP)单独或联合对血清硬化蛋白和骨转换标志物的影响。3年随访显示,SHEP单独或联合欧米伽-3可降低硬化蛋白水平,而维生素D3和欧米伽-3单独补充未显著改变硬化蛋白;P1NP和β-CTx各治疗组均无显著影响。
要点
- SHEP单独较对照运动使硬化蛋白多降低1.56 pmol/L(P=0.002)。
- 欧米伽-3联合SHEP较无欧米伽-3/对照运动多降低硬化蛋白1.93 pmol/L(P=0.007)。
- 维生素D3和欧米伽-3单独补充未显著改变硬化蛋白水平。
核心结论
- 在70岁及以上、多数维生素D充足的老年人中,SHEP单独或联合欧米伽-3降低血清硬化蛋白水平,而维生素D3和欧米伽-3单独不影响血清硬化蛋白水平。
研究设计与样本
- DO-HEALTH为双盲随机对照试验,在5个欧洲国家纳入健康且体力活动的老年人。
- 本分析纳入1848名参与者,平均年龄74.8±4.4岁,58.9%为女性。
- 干预包括2000 IU/天维生素D3、1 g/天欧米伽-3脂肪酸和简易家庭力量锻炼项目(SHEP),单独或联合使用。
- 硬化蛋白、P1NP和β-CTx为预设二次结局,分析3年间年度血清水平变化,校正年龄、性别、既往跌倒、研究 site、基线BMI和相应结局基线水平。
主要发现
- 维生素D3和欧米伽-3单独补充未显著改变硬化蛋白水平。
- P1NP和β-CTx在任何单一治疗及治疗组合中均无显著影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Sclerostin inhibits canonical Wnt signaling, a pathway promoting bone formation. The effects of vitamin D3, omega-3 fatty acids (omega-3s), and exercise on serum sclerostin levels and bone metabolism are unclear. OBJECTIVE: To investigate the effects of 2000 IU/day vitamin D3, 1 g/day omega-3s, and a simple home-based strength exercise program (SHEP), alone or in combination, on serum sclerostin and bone turnover marker levels. METHODS: Sclerostin, procollagen type 1 N propeptide (P1NP) and C-terminal telopeptide (β-CTx) levels were predefined secondary outcomes of DO-HEALTH, a double blind, randomized controlled trial in healthy physically active older adults in 5 European countries. Outcome measures were changes in yearly serum sclerostin, P1NP, and β-CTx levels over 3 years, adjusted for age, sex, prior falls, study site, baseline body mass index, and baseline level of the respective outcome. RESULTS: A total of 1848 participants were included (mean age 74.8 ± 4.4 years, 58.9% women, 41.4% 25(OH)D < 20 ng/mL, 83.9% at least moderately physically active at baseline). Vitamin D3 and omega-3s supplementation alone did not change sclerostin levels significantly, while SHEP compared with control exercise (joint mobility) led to greater decrease in sclerostin levels (-1.56 pmol/L [-2.54, -0.58], P = .002). Omega-3s plus SHEP led to a greater decrease in sclerostin levels than no omega-3s/control exercise (-1.93 pmol/L [-3.31, -0.54], P = .007). For P1NP and β-CTx there were no significant effects for any of the individual treatments and treatment combinations. CONCLUSION: In this 3-year prevention trial among largely vitamin D replete adults age 70 and older, SHEP alone or in combination with omega-3s reduced serum sclerostin levels, while vitamin D3 and omega-3s alone did not affect serum sclerostin levels.
引用
- Tsourdi E, Gängler S, Kistler-Fischbacher M, et al. Effect of Vitamin D3, Omega-3 Fatty Acids, and Exercise on Serum Sclerostin Levels and Bone Turnover Markers. J Clin Endocrinol Metab. 2025. PMID: 39657964. doi:10.1210/clinem/dgae859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。